JP2000508301A5 - - Google Patents

Download PDF

Info

Publication number
JP2000508301A5
JP2000508301A5 JP1997535795A JP53579597A JP2000508301A5 JP 2000508301 A5 JP2000508301 A5 JP 2000508301A5 JP 1997535795 A JP1997535795 A JP 1997535795A JP 53579597 A JP53579597 A JP 53579597A JP 2000508301 A5 JP2000508301 A5 JP 2000508301A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997535795A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000508301A (ja
JP4257870B2 (ja
Filing date
Publication date
Priority claimed from DE19613972A external-priority patent/DE19613972A1/de
Application filed filed Critical
Publication of JP2000508301A publication Critical patent/JP2000508301A/ja
Publication of JP2000508301A5 publication Critical patent/JP2000508301A5/ja
Application granted granted Critical
Publication of JP4257870B2 publication Critical patent/JP4257870B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53579597A 1996-04-09 1997-03-27 ヒマシ油を基とする注射用アベルメクチン含有およびミルベマイシン含有調剤 Expired - Fee Related JP4257870B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19613972.4 1996-04-09
DE19613972A DE19613972A1 (de) 1996-04-09 1996-04-09 Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
PCT/EP1997/001569 WO1997037653A1 (de) 1996-04-09 1997-03-27 Injektionsformulierungen von avermectinen und milbemycinen auf basis von rizinusöl

Publications (3)

Publication Number Publication Date
JP2000508301A JP2000508301A (ja) 2000-07-04
JP2000508301A5 true JP2000508301A5 (cg-RX-API-DMAC10.html) 2004-10-28
JP4257870B2 JP4257870B2 (ja) 2009-04-22

Family

ID=7790774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53579597A Expired - Fee Related JP4257870B2 (ja) 1996-04-09 1997-03-27 ヒマシ油を基とする注射用アベルメクチン含有およびミルベマイシン含有調剤

Country Status (13)

Country Link
US (1) US6063394A (cg-RX-API-DMAC10.html)
EP (1) EP0896534B1 (cg-RX-API-DMAC10.html)
JP (1) JP4257870B2 (cg-RX-API-DMAC10.html)
CN (1) CN1095662C (cg-RX-API-DMAC10.html)
AT (1) ATE285233T1 (cg-RX-API-DMAC10.html)
AU (1) AU718807B2 (cg-RX-API-DMAC10.html)
BR (1) BR9708540B1 (cg-RX-API-DMAC10.html)
CA (1) CA2251087C (cg-RX-API-DMAC10.html)
DE (2) DE19613972A1 (cg-RX-API-DMAC10.html)
ES (1) ES2235230T3 (cg-RX-API-DMAC10.html)
NZ (1) NZ332224A (cg-RX-API-DMAC10.html)
PT (1) PT896534E (cg-RX-API-DMAC10.html)
WO (1) WO1997037653A1 (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
HU228617B1 (en) * 1997-12-03 2013-04-29 Merial Llc Long acting injectable formulations containing hydrogenated castor oil
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
GB9827727D0 (en) * 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US20050009762A1 (en) * 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
CN1275589C (zh) * 2002-05-31 2006-09-20 王玉万 含抗寄生虫药物的缓释注射剂
US7262214B2 (en) 2003-02-26 2007-08-28 Merial Limited 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases
US20050271459A1 (en) * 2004-06-03 2005-12-08 World Wide Stationery Mfg. Co., Ltd. Interlocking ring tip formations for paired ring members of a ring binder mechanism
NZ534939A (en) * 2004-08-26 2007-04-27 Bomac Research Ltd Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
CN101842079B (zh) * 2007-08-31 2012-09-05 阿基米德开发有限公司 非水性药物组合物
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
EP2396006B1 (en) 2009-02-16 2012-12-19 Pfizer Inc. High dosage doramectin formulation
CN101773467B (zh) * 2010-01-20 2015-09-09 北京大北农动物保健科技有限责任公司 一种美贝霉素或美贝霉素肟的兽用缓释注射液及制备方法
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
KR20140136005A (ko) * 2012-03-13 2014-11-27 바이엘 뉴질랜드 리미티드 지속성 조성물
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN119157876A (zh) 2017-12-15 2024-12-20 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
AU2020231319A1 (en) * 2019-03-01 2021-10-21 Boehringer Ingelheim Animal Health USA Inc. Injectable clorsulon compositions, methods and uses thereof
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11918572B2 (en) * 2022-01-28 2024-03-05 Rebel Medicine Inc Pharmaceutical compositions for treating pain
CN114642632A (zh) * 2022-02-25 2022-06-21 河北科技大学 一种莫西克汀注射液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4914624A (cg-RX-API-DMAC10.html) * 1972-06-08 1974-02-08
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
OA06863A (fr) * 1980-08-04 1983-02-28 Merck & Co Inc Solubilisation de l'invermectine dans l'eau.
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
DE3727648A1 (de) * 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
US5510117A (en) * 1989-03-09 1996-04-23 Micro-Pak, Inc. Entrapment vehicle and method
ES2052173T3 (es) * 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
DE69208765T2 (de) * 1991-07-23 1996-09-26 American Cyanamid Co Stabile Zusammensetzungen für parenterale Verabrechung und ihre Verwendung
ES2131515T3 (es) * 1991-09-30 1999-08-01 Merck & Co Inc Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
WO1994008566A1 (en) * 1992-10-21 1994-04-28 Micro Vesicular Systems, Inc. Entrapment vehicle and method

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000504884A5 (cg-RX-API-DMAC10.html)
JP2000516561A5 (cg-RX-API-DMAC10.html)
JP2000501018A5 (cg-RX-API-DMAC10.html)
JP2000500076A5 (cg-RX-API-DMAC10.html)
JP2000501324A5 (cg-RX-API-DMAC10.html)
JP2000500055A5 (cg-RX-API-DMAC10.html)
JP2000500026A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000501338A5 (cg-RX-API-DMAC10.html)
JP2000500874A5 (cg-RX-API-DMAC10.html)
JP2002514951A5 (cg-RX-API-DMAC10.html)
JP2001502959A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000500912A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000505355A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000500857A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)